MILPITAS, Calif.--(BUSINESS WIRE)--Bigfoot Biomedical (Bigfoot), a leader in developing intelligent connected injection support systems, today announced the acquisition of a reinforcement learning ...

Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...

The Food and Drug Administration has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with Type 1 diabetes. These two devices, along ...

A wearable device pairs glucose-responsive insulin with algorithmic pump control, creating dual safety loops that reduced ...

CHARLOTTE, N.C.--(BUSINESS WIRE)--Monarch Medical Technologies, the leader in precision insulin dosing for optimized inpatient glucose management, today announced U.S. Food and Drug Administration ...

Please provide your email address to receive an email when new articles are posted on . The FDA cleared the iLet ACE insulin pump and iLet dosing decision software for people with type 1 diabetes. The ...

A connected therapeutics company has received 510(k) clearance from the U.S. Food and Drug Administration for a physician-driven dosage management platform for basal insulin geared for Type 2 diabetes ...

There may be another leap toward an artificial pancreas thanks to new research released by Animas Corp. At the Advanced Technologies & Treatments for Diabetes Conference in February, the company, part ...

Senseonics shares gain after Eversense 365 became the first one-year implantable CGM integrated with an automated insulin ...

The US Food and Drug Administration has cleared new decision-support software that aids in insulin dosing. In addition, Insulin Algorithms is "an affordable, easily adoptable tool for every-size ...

Abbott Laboratories is linking its continuous glucose monitoring with automated insulin delivery by entering a global partnership with health tech giant Medtronic. The pairing of Abbott's leading ...

The algorithm (Fig. 2) takes into account the characteristics of the individual interventions, their synergies, and expense. The goal is to achieve and maintain glycemic levels as close to the ...